Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12904068rdf:typepubmed:Citationlld:pubmed
pubmed-article:12904068lifeskim:mentionsumls-concept:C0001473lld:lifeskim
pubmed-article:12904068lifeskim:mentionsumls-concept:C1446409lld:lifeskim
pubmed-article:12904068lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:12904068lifeskim:mentionsumls-concept:C1441547lld:lifeskim
pubmed-article:12904068lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:12904068lifeskim:mentionsumls-concept:C0597484lld:lifeskim
pubmed-article:12904068lifeskim:mentionsumls-concept:C0243077lld:lifeskim
pubmed-article:12904068lifeskim:mentionsumls-concept:C0679622lld:lifeskim
pubmed-article:12904068lifeskim:mentionsumls-concept:C1707689lld:lifeskim
pubmed-article:12904068lifeskim:mentionsumls-concept:C0205314lld:lifeskim
pubmed-article:12904068lifeskim:mentionsumls-concept:C0205198lld:lifeskim
pubmed-article:12904068pubmed:issue17lld:pubmed
pubmed-article:12904068pubmed:dateCreated2003-8-7lld:pubmed
pubmed-article:12904068pubmed:abstractTextThe design, synthesis, and biological properties of novel inhibitors of the Na(+),K(+)-ATPase as potential positive inotropic compounds are reported. Following our model of superposition between cassaine and digitoxigenin, digitalis-like activity has been elicited from a non-digitalis steroidal structure by suitable modifications of the 5alpha,14alpha-androstane skeleton. The strong hydrophobic interaction of the digitalis or cassaine polycyclic cores can be effectively obtained with the androstane skeleton taken in a reversed orientation. Thus, oxidation of C-6 and introduction in the C-3 position of the potent pharmacophoric group recently introduced by us, in the 17 position of the digitalis skeleton, namely, O-(omega-aminoalkyl)oxime, led to a series of substituted androstanes able to inhibit the Na(+),K(+)-ATPase, most of them with an IC(50) in the low micromolar level, and to induce a positive inotropic effect in guinea pig. Within this series, androstane-3,6,17-trione (E,Z)-3-(2-aminoethyl)oxime (22b, PST 2744) induced a strong positive inotropic effect while being less arrhythmogenic than digoxin, when the two compounds were compared at equiinotropic doses.lld:pubmed
pubmed-article:12904068pubmed:languageenglld:pubmed
pubmed-article:12904068pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12904068pubmed:citationSubsetIMlld:pubmed
pubmed-article:12904068pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12904068pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12904068pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12904068pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12904068pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12904068pubmed:statusMEDLINElld:pubmed
pubmed-article:12904068pubmed:monthAuglld:pubmed
pubmed-article:12904068pubmed:issn0022-2623lld:pubmed
pubmed-article:12904068pubmed:authorpubmed-author:CerriAlbertoAlld:pubmed
pubmed-article:12904068pubmed:authorpubmed-author:AlmiranteNico...lld:pubmed
pubmed-article:12904068pubmed:authorpubmed-author:De...lld:pubmed
pubmed-article:12904068pubmed:authorpubmed-author:MarazziGiusep...lld:pubmed
pubmed-article:12904068pubmed:authorpubmed-author:MelloniPieroPlld:pubmed
pubmed-article:12904068pubmed:authorpubmed-author:FerrariPatriz...lld:pubmed
pubmed-article:12904068pubmed:authorpubmed-author:TorriMarcoMlld:pubmed
pubmed-article:12904068pubmed:authorpubmed-author:GobbiniMauroMlld:pubmed
pubmed-article:12904068pubmed:authorpubmed-author:BanfiLeonardo...lld:pubmed
pubmed-article:12904068pubmed:authorpubmed-author:CarzanaGiulio...lld:pubmed
pubmed-article:12904068pubmed:authorpubmed-author:MichelettiRos...lld:pubmed
pubmed-article:12904068pubmed:authorpubmed-author:SchiavoneAnto...lld:pubmed
pubmed-article:12904068pubmed:authorpubmed-author:SputoreSimona...lld:pubmed
pubmed-article:12904068pubmed:authorpubmed-author:ZappavignaMar...lld:pubmed
pubmed-article:12904068pubmed:issnTypePrintlld:pubmed
pubmed-article:12904068pubmed:day14lld:pubmed
pubmed-article:12904068pubmed:volume46lld:pubmed
pubmed-article:12904068pubmed:ownerNLMlld:pubmed
pubmed-article:12904068pubmed:authorsCompleteYlld:pubmed
pubmed-article:12904068pubmed:pagination3644-54lld:pubmed
pubmed-article:12904068pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:12904068pubmed:meshHeadingpubmed-meshheading:12904068...lld:pubmed
pubmed-article:12904068pubmed:meshHeadingpubmed-meshheading:12904068...lld:pubmed
pubmed-article:12904068pubmed:meshHeadingpubmed-meshheading:12904068...lld:pubmed
pubmed-article:12904068pubmed:meshHeadingpubmed-meshheading:12904068...lld:pubmed
pubmed-article:12904068pubmed:meshHeadingpubmed-meshheading:12904068...lld:pubmed
pubmed-article:12904068pubmed:meshHeadingpubmed-meshheading:12904068...lld:pubmed
pubmed-article:12904068pubmed:meshHeadingpubmed-meshheading:12904068...lld:pubmed
pubmed-article:12904068pubmed:meshHeadingpubmed-meshheading:12904068...lld:pubmed
pubmed-article:12904068pubmed:meshHeadingpubmed-meshheading:12904068...lld:pubmed
pubmed-article:12904068pubmed:meshHeadingpubmed-meshheading:12904068...lld:pubmed
pubmed-article:12904068pubmed:meshHeadingpubmed-meshheading:12904068...lld:pubmed
pubmed-article:12904068pubmed:meshHeadingpubmed-meshheading:12904068...lld:pubmed
pubmed-article:12904068pubmed:meshHeadingpubmed-meshheading:12904068...lld:pubmed
pubmed-article:12904068pubmed:year2003lld:pubmed
pubmed-article:12904068pubmed:articleTitleStructure-based design and synthesis of novel potent Na+,K+ -ATPase inhibitors derived from a 5alpha,14alpha-androstane scaffold as positive inotropic compounds.lld:pubmed
pubmed-article:12904068pubmed:affiliationDepartment of Medicinal Chemistry, Prassis Istituto di Ricerche Sigma-Tau, Via Forlanini 3, 20019 Settimo Milanese, Milan, Italy.lld:pubmed
pubmed-article:12904068pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:12904068lld:chembl